-
Signature
-
Janet Lee, Attorney-in-Fact
-
Issuer symbol
-
ANSS
-
Transactions as of
-
18 Jul 2023
-
Transactions value $
-
$-6,209,442
-
Form type
-
4
-
Filing time
-
20 Jul 2023, 17:00:11 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ANSS |
Common Stock |
Options Exercise |
$1,261,084 |
+13,262 |
+6.2% |
$95.09 |
227,239 |
18 Jul 2023 |
Direct |
|
| transaction |
ANSS |
Common Stock |
Sale |
$-4,642,230 |
-13,262 |
-5.84% |
$350.04 |
213,977 |
18 Jul 2023 |
Direct |
F1, F2 |
| transaction |
ANSS |
Common Stock |
Options Exercise |
$1,054,263 |
+11,087 |
+5.18% |
$95.09 |
225,064 |
19 Jul 2023 |
Direct |
|
| transaction |
ANSS |
Common Stock |
Sale |
$-3,707,038 |
-10,587 |
-4.7% |
$350.15 |
214,477 |
19 Jul 2023 |
Direct |
F1, F3 |
| transaction |
ANSS |
Common Stock |
Sale |
$-175,520 |
-500 |
-0.23% |
$351.04 |
213,977 |
19 Jul 2023 |
Direct |
F1, F4, F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ANSS |
Option To Purchase |
Options Exercise |
$0 |
-13,262 |
-8.47% |
$0.000000 |
143,399 |
18 Jul 2023 |
Common Stock |
13,262 |
$95.09 |
Direct |
F6 |
| transaction |
ANSS |
Option to Purchase |
Options Exercise |
$0 |
-11,087 |
-7.73% |
$0.000000 |
132,312 |
19 Jul 2023 |
Common Stock |
11,087 |
$95.09 |
Direct |
F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: